Long-acting pharmacotherapies targeting incretin hormones like glucagon-like peptide-1 (GLP-1) and glucose-dependent ...

Global diabetes rates have surged, particularly in low-resource areas, revealing critical gaps in treatment access and ...

The study is the first set of global estimates directly linking diabetes prevalence with treatment coverage over a ...

The total number of adults living with either type 1 or type 2 diabetes in the world has surpassed 800 million—over four ...

Fourteen percent of the world's people -- more than 800 million -- now have diabetes, a doubling of the global rate for the ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

Spanning 176 weeks of treatment, the Phase III trial evaluated the efficacy and safety of tirzepatide in adults without type ...

New technologies and treatments revolutionizing diabetes care: Dr Ajay Aggarwal: Shardul Nautiyal, Mumbai Saturday, November 16, 2024, 08:00 Hrs [IST] As diabetes continues to ris ...

A new study found that over 800 million adults have diabetes worldwide — almost twice as many as previous estimates have ...

The study, backed by the WHO, was released to mark World Diabetes Day on Thursday. It conducts a comparison between the ...